
Cancers | Feature Papers from the Second Half of 2025 in the “Cancer Immunology and Immunotherapy” Section
8 July 2026
As Cancers (ISSN 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2025 in the “Cancer Immunology and Immunotherapy” Section, which are listed below:
- “Expanding Immunotherapy Beyond CAR T Cells: Engineering Diverse Immune Cells to Target Solid Tumors”
by Tereza Andreou, Constantina Neophytou, Fotios Mpekris and Triantafyllos Stylianopoulos
Cancers 2025, 17(17), 2917; https://doi.org/10.3390/cancers17172917
Available online: https://www.mdpi.com/2072-6694/17/17/2917 - “A Review of Immunotherapy in Renal Cell Carcinoma: Current Landscape and Future Directions”
by Supriya Peshin, Adit Dharia, Nagaishwarya Moka and William Paul Skelton, IV
Cancers 2025, 17(19), 3139; https://doi.org/10.3390/cancers17193139
Available online: https://www.mdpi.com/2072-6694/17/19/3139 - “Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology”
by Eleni Stefanou, Georgios Tsitsinakis, Dimitra Karageorgou and Christo Kole
Cancers 2025, 17(17), 2838; https://doi.org/10.3390/cancers17172838
Available online: https://www.mdpi.com/2072-6694/17/17/2838 - “Bispecific Antibodies and Antibody–Drug Conjugates in Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma, Focusing on Diffuse Large B-Cell Lymphoma”
by Santino Caserta, Chiara Campo, Gabriella Cancemi, Santo Neri, Fabio Stagno, Donato Mannina and Alessandro Allegra
Cancers 2025, 17(15), 2479; https://doi.org/10.3390/cancers17152479
Available online: https://www.mdpi.com/2072-6694/17/15/2479 - “T-Cell Engagers in Acute Myeloid Leukemia: Molecular Targets, Structure, and Therapeutic Challenges”
by Hunter Daws, Kate Gallinero, Amanda Singh and Sanela Bilic
Cancers 2025, 17(19), 3246; https://doi.org/10.3390/cancers17193246
Available online: https://www.mdpi.com/2072-6694/17/19/3246 - “Oncolytic Virus Therapies in Malignant Gliomas: Advances and Clinical Trials”
by Rin Yang, Jack Hedberg, Jordan Montagano, Malik Seals and Sushant Puri
Cancers 2025, 17(19), 3180; https://doi.org/10.3390/cancers17193180
Available online: https://www.mdpi.com/2072-6694/17/19/3180 - “Vaccinia Virus—A Swiss Army Knife Against Cancer”
by Marcin Stawowczyk, Yanqi Ye and Nanhai G. Chen
Cancers 2025, 17(14), 2324; https://doi.org/10.3390/cancers17142324
Available online: https://www.mdpi.com/2072-6694/17/14/2324 - “Influence of Genetic, Dietary, and Environmental Factors on Natural Killer (NK) Cell Biology and Function: Interplay Between NK Cell Activity and Cancer Onset or Progression”
by Kawaljit Kaur
Cancers 2025, 17(18), 2946; https://doi.org/10.3390/cancers17182946
Available online: https://www.mdpi.com/2072-6694/17/18/2946 - “Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and Cancer”
by Giovanna Talarico, Stefania Orecchioni, Paolo Falvo and Francesco Bertolini
Cancers 2025, 17(13), 2251; https://doi.org/10.3390/cancers17132251
Available online: https://www.mdpi.com/2072-6694/17/13/2251 - “Emerging Techniques of Translational Research in Immuno-Oncology: A Focus on Non-Small Cell Lung Cancer”
by Mora Guardamagna, Eduardo Zamorano, Victor Albarrán-Artahona, Andres Mesas and Jose Carlos Benitez
Cancers 2025, 17(13), 2244; https://doi.org/10.3390/cancers17132244
Available online: https://www.mdpi.com/2072-6694/17/13/2244
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office